PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval [Yahoo! Finance]
Verisk Analytics, Inc. (VRSK)
Last verisk analytics, inc. earnings: 2/18 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.verisk.com/overview/default.aspx
Company Research
Source: Yahoo! Finance
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights the FDA's landmark approval of Rezdiffra™, and the companies leading the charge in developing new, safe and effective treatments for liver disease. The landmark decision has shone a light on metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic fatty liver disease, a leading cause of liver-related mortality that affects between six and eight million adults in the US. The number of MASH cases is expected to skyrocket to an estimated 27 million cases in the US by 2030, according to the Global Liver Institute In 2023, liver disease received a much-needed rebrand, removing the words ‘fatty' and ‘alcohol' from the names, which has left patients feeling stigmatized and their illness trivialized. Experts believe this overhaul may be the rebrand that liver disease needs to generate better clinical results for sp
Show less
Read more
Impact Snapshot
Event Time:
VRSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRSK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRSK alerts
High impacting Verisk Analytics, Inc. news events
Weekly update
A roundup of the hottest topics
VRSK
News
- Baron Asset Fund Q1 2024 Shareholder Letter [Seeking Alpha]Seeking Alpha
- Verisk Analytics, Inc. (NASDAQ: VRSK) had its price target raised by analysts at BMO Capital Markets from $238.00 to $241.00. They now have a "market perform" rating on the stock.MarketBeat
- Verisk Analytics (NASDAQ:VRSK) Ticks All The Boxes When It Comes To Earnings Growth [Yahoo! Finance]Yahoo! Finance
- Verisk (VRSK) Earnings & Revenues Surpass Estimates in Q1 [Yahoo! Finance]Yahoo! Finance
- Verisk Reports First-Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
VRSK
Earnings
- 5/1/24 - Beat
VRSK
Sec Filings
- 5/3/24 - Form 144
- 5/3/24 - Form 4
- 5/3/24 - Form 4
- VRSK's page on the SEC website